Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: From bedside to bench
暂无分享,去创建一个
D. Ballon | C. Hofstetter | J. Boockvar | C. Foley | Y. Gobin | B. Shin | J. Burkhardt | A. Santillan
[1] K. Camphausen,et al. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma , 2012, Journal of cellular and molecular medicine.
[2] C. Hofstetter,et al. Intra-Arterial Chemotherapy for Malignant Gliomas: A Critical Analysis , 2011, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.
[3] M. Chopp,et al. Effect of doublecortin on self‐renewal and differentiation in brain tumor stem cells , 2011, Cancer science.
[4] J. Boockvar,et al. Understanding the role of tumor stem cells in glioblastoma multiforme: a review article , 2011, Journal of Neuro-Oncology.
[5] S. Brodie,et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. , 2011, Archives of ophthalmology.
[6] T. Schwartz,et al. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article. , 2011, Journal of neurosurgery.
[7] M. Souweidane,et al. Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction , 2011, Journal of Neuro-Oncology.
[8] Rong Wang,et al. Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.
[9] A. Falini,et al. Cancer esearch cular and Cellular Pathobiology ermal Growth Factor Receptor Expression Identifies ctionally and Molecularly Distinct Tumor-Initiating Cells uman Glioblastoma Multiforme and Is Required R Gliomagenesis , 2010 .
[10] A. Ciurea,et al. Infiltrating growing pattern xenografts induced by glioblastoma and anaplastic astrocytoma derived tumor stem cells. , 2010, Chirurgia.
[11] C. Eberhart,et al. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. , 2010, The American journal of pathology.
[12] V. Tse,et al. Firefly Luciferase–Based Dynamic Bioluminescence Imaging: A Noninvasive Technique to Assess Tumor Angiogenesis , 2010, Neurosurgery.
[13] M. Souweidane,et al. Balloon-Assisted Superselective Intra-Arterial Cerebral Infusion of Bevacizumab for Malignant Brainstem Glioma , 2010, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.
[14] J. Beijnen,et al. High-grade glioma mouse models and their applicability for preclinical testing. , 2009, Cancer treatment reviews.
[15] P. Keegan,et al. FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. , 2009, The oncologist.
[16] Susan Bell,et al. Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Michael D. Prados,et al. A human brainstem glioma xenograft model enabled for bioluminescence imaging , 2009, Journal of Neuro-Oncology.
[18] Colin M. Wilson,et al. Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors , 2009, Journal of Translational Medicine.
[19] D. Ballon,et al. Novel Microcatheters for Selective Intra-Arterial Injection of Fluid in the Rat Brain , 2009, American Journal of Neuroradiology.
[20] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[21] P. Dirks,et al. Brain tumor stem cells: bringing order to the chaos of brain cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] L. Abrey. Bevacizumab in recurrent malignant glioma , 2008, Current neurology and neuroscience reports.
[23] Kornelia Polyak,et al. The cancer stem cell hypothesis: in search of definitions, markers, and relevance , 2008, Laboratory Investigation.
[24] Darell D. Bigner,et al. Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma , 2007, Clinical Cancer Research.
[25] H. Newton. Intra-arterial chemotherapy of primary brain tumors , 2005, Current treatment options in oncology.
[26] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[27] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[28] R A Moats,et al. Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. , 2003, BioTechniques.
[29] C. Hofstetter,et al. Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival. , 2012, World neurosurgery.
[30] J. Knopman,et al. Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. , 2009, Journal of experimental therapeutics & oncology.
[31] C. Altaner,et al. Glioblastoma and stem cells. , 2008, Neoplasma.
[32] I. Bayazitov,et al. A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.